Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Current pharmaceutical design ; h5-index 57.0

PURPOSE : Improving hypertension management is still one of the severest challenges in public health worldwide. Existing guidelines do not reach a consensus on the optimal Blood Pressure (BP) target. Therefore, how to effectively manage hypertension based on individual characteristics of patients, combined with pharmacological and nonpharmacological approach, has become a problem to be urgently considered.

METHODS : Reports published in PubMed that covered Pharmacological and Non-Pharmacological Approaches in subjects taking hypertension management were reviewed by the group independently and collectively. Practical recommendations for hypertension management were established by the panel.

RESULTS : Pharmacological mechanism, action characteristics and main adverse reactions varied across different pharmacological agents, and patients with hypertension often require a combination of antihypertensive medications to achieve target BP range. Non-pharmacological treatment provides an additional effective method for improving therapy adherence and long-term BP control, reducing Cardiovascular Diseases risk and slowing down the progression of the disease.

CONCLUSION : This review summarizes the available literature on the most convincing Guideline-principles, pharmacological treatment, biotechnology interference, interventional surgical treatment, managing hypertension with technical means of big data, Artificial Intelligence and Behavioral Intervention, as well as providing future directions, for facilitating Current and Developing knowledge into clinical implementation.

Hong Dongsheng, Shan Wenya

2020-Sep-22

Antihypertensive drugs, artificial intelligence, biotechnology interference, hypertension management, pharmacological approaches\n